Pieris Pharmaceuticals proposes follow-on

Pieris Pharmaceuticals Inc. (OTCQB:PIRS), Freising-Weihenstephan, Germany Business: Autoimmune, Inflammation, Cancer Date announced: 2015-06-09 Type: Follow-on To be raised: Up to $34.5 million Shares...